nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—breast cancer	0.158	0.522	CbGaD
Apixaban—CYP3A4—breast cancer	0.0789	0.261	CbGaD
Apixaban—ABCB1—breast cancer	0.0657	0.217	CbGaD
Apixaban—CYP1A2—Anastrozole—breast cancer	0.0185	0.0398	CbGbCtD
Apixaban—CYP1A2—Toremifene—breast cancer	0.017	0.0364	CbGbCtD
Apixaban—CYP2C9—Anastrozole—breast cancer	0.0167	0.0358	CbGbCtD
Apixaban—CYP3A5—Lapatinib—breast cancer	0.0166	0.0356	CbGbCtD
Apixaban—CYP2C8—Lapatinib—breast cancer	0.016	0.0343	CbGbCtD
Apixaban—ABCG2—Tamoxifen—breast cancer	0.015	0.0322	CbGbCtD
Apixaban—ABCB1—Toremifene—breast cancer	0.0148	0.0318	CbGbCtD
Apixaban—ABCG2—Mitoxantrone—breast cancer	0.0147	0.0314	CbGbCtD
Apixaban—CYP2C19—Lapatinib—breast cancer	0.0134	0.0288	CbGbCtD
Apixaban—CYP3A4—Exemestane—breast cancer	0.0128	0.0275	CbGbCtD
Apixaban—CYP2C9—Idarubicin—breast cancer	0.0127	0.0272	CbGbCtD
Apixaban—CYP2C8—Raloxifene—breast cancer	0.0121	0.026	CbGbCtD
Apixaban—ABCG2—Paclitaxel—breast cancer	0.0117	0.0251	CbGbCtD
Apixaban—ABCG2—Irinotecan—breast cancer	0.0115	0.0247	CbGbCtD
Apixaban—ABCG2—Fluorouracil—breast cancer	0.0111	0.0237	CbGbCtD
Apixaban—ABCG2—Carboplatin—breast cancer	0.011	0.0236	CbGbCtD
Apixaban—CYP3A4—Letrozole—breast cancer	0.0109	0.0234	CbGbCtD
Apixaban—ABCB1—Lapatinib—breast cancer	0.0108	0.0232	CbGbCtD
Apixaban—CYP3A4—Anastrozole—breast cancer	0.00971	0.0208	CbGbCtD
Apixaban—CYP3A4—Toremifene—breast cancer	0.00888	0.0191	CbGbCtD
Apixaban—ABCG2—Docetaxel—breast cancer	0.00845	0.0181	CbGbCtD
Apixaban—CYP3A5—Tamoxifen—breast cancer	0.00832	0.0178	CbGbCtD
Apixaban—CYP3A4—Fulvestrant—breast cancer	0.00826	0.0177	CbGbCtD
Apixaban—CYP2C8—Tamoxifen—breast cancer	0.008	0.0172	CbGbCtD
Apixaban—CYP3A4—Thiotepa—breast cancer	0.00736	0.0158	CbGbCtD
Apixaban—CYP2C9—Capecitabine—breast cancer	0.00694	0.0149	CbGbCtD
Apixaban—CYP3A4—Ixabepilone—breast cancer	0.00673	0.0144	CbGbCtD
Apixaban—CYP2C19—Tamoxifen—breast cancer	0.00671	0.0144	CbGbCtD
Apixaban—CYP3A4—Lapatinib—breast cancer	0.00648	0.0139	CbGbCtD
Apixaban—CYP3A5—Paclitaxel—breast cancer	0.00648	0.0139	CbGbCtD
Apixaban—CYP3A5—Irinotecan—breast cancer	0.00639	0.0137	CbGbCtD
Apixaban—ABCG2—Doxorubicin—breast cancer	0.0063	0.0135	CbGbCtD
Apixaban—CYP2C8—Paclitaxel—breast cancer	0.00623	0.0134	CbGbCtD
Apixaban—CYP1A2—Tamoxifen—breast cancer	0.00619	0.0133	CbGbCtD
Apixaban—ABCG2—Methotrexate—breast cancer	0.0061	0.0131	CbGbCtD
Apixaban—ABCB1—Vinorelbine—breast cancer	0.006	0.0129	CbGbCtD
Apixaban—CYP2C8—Fluorouracil—breast cancer	0.0059	0.0126	CbGbCtD
Apixaban—CYP2C9—Tamoxifen—breast cancer	0.00558	0.012	CbGbCtD
Apixaban—ABCB1—Tamoxifen—breast cancer	0.00542	0.0116	CbGbCtD
Apixaban—ABCB1—Mitoxantrone—breast cancer	0.00528	0.0113	CbGbCtD
Apixaban—CYP3A4—Raloxifene—breast cancer	0.00491	0.0105	CbGbCtD
Apixaban—CYP3A5—Docetaxel—breast cancer	0.00468	0.01	CbGbCtD
Apixaban—ABCB1—Gemcitabine—breast cancer	0.00467	0.01	CbGbCtD
Apixaban—CYP1A2—Fluorouracil—breast cancer	0.00456	0.00979	CbGbCtD
Apixaban—CYP2C9—Paclitaxel—breast cancer	0.00434	0.00932	CbGbCtD
Apixaban—ABCB1—Paclitaxel—breast cancer	0.00422	0.00904	CbGbCtD
Apixaban—ABCB1—Irinotecan—breast cancer	0.00416	0.00892	CbGbCtD
Apixaban—CYP2C9—Fluorouracil—breast cancer	0.00411	0.00882	CbGbCtD
Apixaban—ABCB1—Vinblastine—breast cancer	0.0037	0.00793	CbGbCtD
Apixaban—CYP3A4—Vinorelbine—breast cancer	0.0036	0.00771	CbGbCtD
Apixaban—CYP3A4—Tamoxifen—breast cancer	0.00325	0.00696	CbGbCtD
Apixaban—CYP3A4—Mitoxantrone—breast cancer	0.00317	0.00679	CbGbCtD
Apixaban—ABCB1—Docetaxel—breast cancer	0.00305	0.00654	CbGbCtD
Apixaban—CYP3A4—Paclitaxel—breast cancer	0.00253	0.00542	CbGbCtD
Apixaban—CYP3A4—Irinotecan—breast cancer	0.00249	0.00534	CbGbCtD
Apixaban—ABCB1—Doxorubicin—breast cancer	0.00227	0.00487	CbGbCtD
Apixaban—CYP3A4—Vinblastine—breast cancer	0.00222	0.00475	CbGbCtD
Apixaban—ABCB1—Methotrexate—breast cancer	0.0022	0.00472	CbGbCtD
Apixaban—F10—mammary gland—breast cancer	0.00217	0.0859	CbGeAlD
Apixaban—CYP3A4—Docetaxel—breast cancer	0.00183	0.00392	CbGbCtD
Apixaban—F10—nipple—breast cancer	0.0018	0.0711	CbGeAlD
Apixaban—CYP2J2—nipple—breast cancer	0.00147	0.0582	CbGeAlD
Apixaban—CYP3A4—Doxorubicin—breast cancer	0.00136	0.00292	CbGbCtD
Apixaban—F10—endometrium—breast cancer	0.00108	0.0429	CbGeAlD
Apixaban—F10—adipose tissue—breast cancer	0.000977	0.0387	CbGeAlD
Apixaban—CYP2J2—skin of body—breast cancer	0.000942	0.0373	CbGeAlD
Apixaban—F10—female reproductive system—breast cancer	0.000898	0.0355	CbGeAlD
Apixaban—CYP2J2—endometrium—breast cancer	0.000888	0.0352	CbGeAlD
Apixaban—F10—adrenal gland—breast cancer	0.000876	0.0347	CbGeAlD
Apixaban—CYP2J2—uterus—breast cancer	0.000819	0.0324	CbGeAlD
Apixaban—F10—female gonad—breast cancer	0.000817	0.0323	CbGeAlD
Apixaban—CYP2J2—pituitary gland—breast cancer	0.000804	0.0318	CbGeAlD
Apixaban—F10—endocrine gland—breast cancer	0.00076	0.0301	CbGeAlD
Apixaban—CYP2J2—female reproductive system—breast cancer	0.000736	0.0291	CbGeAlD
Apixaban—CYP2C8—mammary gland—breast cancer	0.000694	0.0275	CbGeAlD
Apixaban—CYP2J2—endocrine gland—breast cancer	0.000623	0.0247	CbGeAlD
Apixaban—CYP2C9—mammary gland—breast cancer	0.000616	0.0244	CbGeAlD
Apixaban—CYP1A2—nipple—breast cancer	0.000537	0.0213	CbGeAlD
Apixaban—F10—lymph node—breast cancer	0.000525	0.0208	CbGeAlD
Apixaban—CYP2C8—endometrium—breast cancer	0.000346	0.0137	CbGeAlD
Apixaban—ABCG2—endometrium—breast cancer	0.000337	0.0133	CbGeAlD
Apixaban—CYP2C8—pituitary gland—breast cancer	0.000313	0.0124	CbGeAlD
Apixaban—ABCG2—uterus—breast cancer	0.00031	0.0123	CbGeAlD
Apixaban—ABCG2—pituitary gland—breast cancer	0.000305	0.0121	CbGeAlD
Apixaban—ABCG2—adipose tissue—breast cancer	0.000304	0.012	CbGeAlD
Apixaban—CYP2C8—female reproductive system—breast cancer	0.000287	0.0114	CbGeAlD
Apixaban—CYP3A5—adipose tissue—breast cancer	0.000282	0.0112	CbGeAlD
Apixaban—CYP2C19—endocrine gland—breast cancer	0.000278	0.011	CbGeAlD
Apixaban—ABCG2—adrenal gland—breast cancer	0.000272	0.0108	CbGeAlD
Apixaban—ABCG2—bone marrow—breast cancer	0.000263	0.0104	CbGeAlD
Apixaban—CYP2C9—female reproductive system—breast cancer	0.000255	0.0101	CbGeAlD
Apixaban—ABCG2—female gonad—breast cancer	0.000254	0.0101	CbGeAlD
Apixaban—CYP2C8—endocrine gland—breast cancer	0.000243	0.00961	CbGeAlD
Apixaban—CYP3A5—female gonad—breast cancer	0.000236	0.00933	CbGeAlD
Apixaban—CYP1A2—endocrine gland—breast cancer	0.000227	0.009	CbGeAlD
Apixaban—ABCB1—embryo—breast cancer	0.000227	0.00899	CbGeAlD
Apixaban—CYP3A5—endocrine gland—breast cancer	0.000219	0.00868	CbGeAlD
Apixaban—CYP2C9—endocrine gland—breast cancer	0.000216	0.00854	CbGeAlD
Apixaban—CYP3A4—female reproductive system—breast cancer	0.000194	0.00769	CbGeAlD
Apixaban—ABCB1—epithelium—breast cancer	0.000185	0.00733	CbGeAlD
Apixaban—ABCB1—endometrium—breast cancer	0.000166	0.00658	CbGeAlD
Apixaban—CYP3A4—endocrine gland—breast cancer	0.000164	0.00651	CbGeAlD
Apixaban—ABCG2—lymph node—breast cancer	0.000163	0.00646	CbGeAlD
Apixaban—ABCB1—uterus—breast cancer	0.000153	0.00606	CbGeAlD
Apixaban—ABCB1—pituitary gland—breast cancer	0.00015	0.00595	CbGeAlD
Apixaban—ABCB1—adipose tissue—breast cancer	0.00015	0.00593	CbGeAlD
Apixaban—ABCB1—female reproductive system—breast cancer	0.000138	0.00545	CbGeAlD
Apixaban—ABCB1—adrenal gland—breast cancer	0.000134	0.00532	CbGeAlD
Apixaban—ABCB1—bone marrow—breast cancer	0.00013	0.00514	CbGeAlD
Apixaban—ABCB1—female gonad—breast cancer	0.000125	0.00496	CbGeAlD
Apixaban—ABCB1—endocrine gland—breast cancer	0.000116	0.00461	CbGeAlD
Apixaban—Anaemia—Irinotecan—breast cancer	9.64e-05	0.000825	CcSEcCtD
Apixaban—Anaemia—Mitoxantrone—breast cancer	9.64e-05	0.000825	CcSEcCtD
Apixaban—Connective tissue disorder—Paclitaxel—breast cancer	9.6e-05	0.000822	CcSEcCtD
Apixaban—Urethral disorder—Paclitaxel—breast cancer	9.58e-05	0.00082	CcSEcCtD
Apixaban—Skin disorder—Thiotepa—breast cancer	9.58e-05	0.00082	CcSEcCtD
Apixaban—Anaemia—Gemcitabine—breast cancer	9.39e-05	0.000804	CcSEcCtD
Apixaban—Syncope—Irinotecan—breast cancer	9.36e-05	0.000801	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—breast cancer	9.31e-05	0.000797	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—breast cancer	9.29e-05	0.000795	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—breast cancer	9.29e-05	0.000795	CcSEcCtD
Apixaban—Anaemia—Fluorouracil—breast cancer	9.23e-05	0.000791	CcSEcCtD
Apixaban—Loss of consciousness—Irinotecan—breast cancer	9.17e-05	0.000785	CcSEcCtD
Apixaban—Hypersensitivity—Vinblastine—breast cancer	9.15e-05	0.000783	CcSEcCtD
Apixaban—Eye disorder—Paclitaxel—breast cancer	9.13e-05	0.000782	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vinorelbine—breast cancer	8.91e-05	0.000763	CcSEcCtD
Apixaban—Hypersensitivity—Tamoxifen—breast cancer	8.89e-05	0.000761	CcSEcCtD
Apixaban—Angiopathy—Paclitaxel—breast cancer	8.87e-05	0.000759	CcSEcCtD
Apixaban—Immune system disorder—Paclitaxel—breast cancer	8.83e-05	0.000756	CcSEcCtD
Apixaban—Mediastinal disorder—Paclitaxel—breast cancer	8.81e-05	0.000754	CcSEcCtD
Apixaban—Hepatobiliary disease—Docetaxel—breast cancer	8.73e-05	0.000747	CcSEcCtD
Apixaban—Hypersensitivity—Melphalan—breast cancer	8.71e-05	0.000745	CcSEcCtD
Apixaban—Epistaxis—Docetaxel—breast cancer	8.7e-05	0.000745	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—breast cancer	8.59e-05	0.000735	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—breast cancer	8.59e-05	0.000735	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	8.59e-05	0.000735	CcSEcCtD
Apixaban—Haematuria—Capecitabine—breast cancer	8.52e-05	0.000729	CcSEcCtD
Apixaban—Anaphylactic shock—Mitoxantrone—breast cancer	8.51e-05	0.000729	CcSEcCtD
Apixaban—Anaphylactic shock—Irinotecan—breast cancer	8.51e-05	0.000729	CcSEcCtD
Apixaban—Gastrointestinal disorder—Thiotepa—breast cancer	8.51e-05	0.000729	CcSEcCtD
Apixaban—Hypersensitivity—Goserelin—breast cancer	8.49e-05	0.000727	CcSEcCtD
Apixaban—Hepatobiliary disease—Capecitabine—breast cancer	8.45e-05	0.000723	CcSEcCtD
Apixaban—Epistaxis—Capecitabine—breast cancer	8.43e-05	0.000721	CcSEcCtD
Apixaban—Shock—Mitoxantrone—breast cancer	8.38e-05	0.000717	CcSEcCtD
Apixaban—Shock—Irinotecan—breast cancer	8.38e-05	0.000717	CcSEcCtD
Apixaban—Nervous system disorder—Irinotecan—breast cancer	8.35e-05	0.000715	CcSEcCtD
Apixaban—Thrombocytopenia—Mitoxantrone—breast cancer	8.34e-05	0.000714	CcSEcCtD
Apixaban—Thrombocytopenia—Irinotecan—breast cancer	8.34e-05	0.000714	CcSEcCtD
Apixaban—Haemoglobin—Docetaxel—breast cancer	8.33e-05	0.000713	CcSEcCtD
Apixaban—Anaphylactic shock—Gemcitabine—breast cancer	8.29e-05	0.00071	CcSEcCtD
Apixaban—Haemorrhage—Docetaxel—breast cancer	8.28e-05	0.000709	CcSEcCtD
Apixaban—Skin disorder—Mitoxantrone—breast cancer	8.27e-05	0.000708	CcSEcCtD
Apixaban—Dizziness—Vinblastine—breast cancer	8.21e-05	0.000703	CcSEcCtD
Apixaban—Urinary tract disorder—Docetaxel—breast cancer	8.18e-05	0.0007	CcSEcCtD
Apixaban—Anaphylactic shock—Fluorouracil—breast cancer	8.15e-05	0.000698	CcSEcCtD
Apixaban—Connective tissue disorder—Docetaxel—breast cancer	8.14e-05	0.000697	CcSEcCtD
Apixaban—Nervous system disorder—Gemcitabine—breast cancer	8.13e-05	0.000696	CcSEcCtD
Apixaban—Urethral disorder—Docetaxel—breast cancer	8.12e-05	0.000695	CcSEcCtD
Apixaban—Thrombocytopenia—Gemcitabine—breast cancer	8.12e-05	0.000695	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—breast cancer	8.08e-05	0.000691	CcSEcCtD
Apixaban—Haemoglobin—Capecitabine—breast cancer	8.06e-05	0.00069	CcSEcCtD
Apixaban—Skin disorder—Gemcitabine—breast cancer	8.06e-05	0.00069	CcSEcCtD
Apixaban—Nausea—Chlorambucil—breast cancer	8.05e-05	0.000689	CcSEcCtD
Apixaban—ABCB1—lymph node—breast cancer	8.05e-05	0.00319	CbGeAlD
Apixaban—Haemorrhage—Capecitabine—breast cancer	8.02e-05	0.000687	CcSEcCtD
Apixaban—Nervous system disorder—Fluorouracil—breast cancer	8e-05	0.000685	CcSEcCtD
Apixaban—Thrombocytopenia—Fluorouracil—breast cancer	7.98e-05	0.000683	CcSEcCtD
Apixaban—Dizziness—Tamoxifen—breast cancer	7.98e-05	0.000683	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—breast cancer	7.97e-05	0.000682	CcSEcCtD
Apixaban—Hypotension—Mitoxantrone—breast cancer	7.96e-05	0.000681	CcSEcCtD
Apixaban—Hypotension—Irinotecan—breast cancer	7.96e-05	0.000681	CcSEcCtD
Apixaban—Urinary tract disorder—Capecitabine—breast cancer	7.92e-05	0.000678	CcSEcCtD
Apixaban—Connective tissue disorder—Capecitabine—breast cancer	7.88e-05	0.000675	CcSEcCtD
Apixaban—Anaemia—Paclitaxel—breast cancer	7.86e-05	0.000673	CcSEcCtD
Apixaban—Urethral disorder—Capecitabine—breast cancer	7.86e-05	0.000673	CcSEcCtD
Apixaban—Breast disorder—Methotrexate—breast cancer	7.8e-05	0.000668	CcSEcCtD
Apixaban—Hypotension—Gemcitabine—breast cancer	7.75e-05	0.000663	CcSEcCtD
Apixaban—Eye disorder—Docetaxel—breast cancer	7.74e-05	0.000663	CcSEcCtD
Apixaban—Syncope—Paclitaxel—breast cancer	7.63e-05	0.000653	CcSEcCtD
Apixaban—Dizziness—Goserelin—breast cancer	7.62e-05	0.000652	CcSEcCtD
Apixaban—Hypotension—Fluorouracil—breast cancer	7.62e-05	0.000652	CcSEcCtD
Apixaban—Rash—Tamoxifen—breast cancer	7.61e-05	0.000651	CcSEcCtD
Apixaban—Hypersensitivity—Vinorelbine—breast cancer	7.61e-05	0.000651	CcSEcCtD
Apixaban—Dermatitis—Tamoxifen—breast cancer	7.6e-05	0.000651	CcSEcCtD
Apixaban—Angiopathy—Docetaxel—breast cancer	7.52e-05	0.000643	CcSEcCtD
Apixaban—Eye disorder—Capecitabine—breast cancer	7.5e-05	0.000642	CcSEcCtD
Apixaban—Immune system disorder—Docetaxel—breast cancer	7.48e-05	0.000641	CcSEcCtD
Apixaban—Loss of consciousness—Paclitaxel—breast cancer	7.48e-05	0.00064	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	7.47e-05	0.00064	CcSEcCtD
Apixaban—Mediastinal disorder—Docetaxel—breast cancer	7.47e-05	0.000639	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—breast cancer	7.46e-05	0.000638	CcSEcCtD
Apixaban—Rash—Melphalan—breast cancer	7.45e-05	0.000638	CcSEcCtD
Apixaban—Dermatitis—Melphalan—breast cancer	7.44e-05	0.000637	CcSEcCtD
Apixaban—Nausea—Vinblastine—breast cancer	7.38e-05	0.000632	CcSEcCtD
Apixaban—Gastrointestinal disorder—Irinotecan—breast cancer	7.35e-05	0.000629	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—breast cancer	7.3e-05	0.000625	CcSEcCtD
Apixaban—Angiopathy—Capecitabine—breast cancer	7.28e-05	0.000623	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—breast cancer	7.27e-05	0.000623	CcSEcCtD
Apixaban—Rash—Goserelin—breast cancer	7.27e-05	0.000622	CcSEcCtD
Apixaban—Hypersensitivity—Thiotepa—breast cancer	7.26e-05	0.000622	CcSEcCtD
Apixaban—Dermatitis—Goserelin—breast cancer	7.26e-05	0.000622	CcSEcCtD
Apixaban—Immune system disorder—Capecitabine—breast cancer	7.24e-05	0.00062	CcSEcCtD
Apixaban—Mediastinal disorder—Capecitabine—breast cancer	7.23e-05	0.000619	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	7.19e-05	0.000616	CcSEcCtD
Apixaban—Nausea—Tamoxifen—breast cancer	7.17e-05	0.000614	CcSEcCtD
Apixaban—Gastrointestinal disorder—Gemcitabine—breast cancer	7.16e-05	0.000613	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—breast cancer	7.12e-05	0.00061	CcSEcCtD
Apixaban—Gastrointestinal disorder—Fluorouracil—breast cancer	7.04e-05	0.000603	CcSEcCtD
Apixaban—Nausea—Melphalan—breast cancer	7.02e-05	0.000601	CcSEcCtD
Apixaban—Anaphylactic shock—Paclitaxel—breast cancer	6.94e-05	0.000594	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—breast cancer	6.9e-05	0.000591	CcSEcCtD
Apixaban—Nausea—Goserelin—breast cancer	6.85e-05	0.000586	CcSEcCtD
Apixaban—Shock—Paclitaxel—breast cancer	6.83e-05	0.000585	CcSEcCtD
Apixaban—Dizziness—Vinorelbine—breast cancer	6.83e-05	0.000584	CcSEcCtD
Apixaban—Nervous system disorder—Paclitaxel—breast cancer	6.81e-05	0.000583	CcSEcCtD
Apixaban—Thrombocytopenia—Paclitaxel—breast cancer	6.8e-05	0.000582	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—breast cancer	6.75e-05	0.000578	CcSEcCtD
Apixaban—Skin disorder—Paclitaxel—breast cancer	6.74e-05	0.000577	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—breast cancer	6.73e-05	0.000576	CcSEcCtD
Apixaban—Anaemia—Docetaxel—breast cancer	6.67e-05	0.000571	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—breast cancer	6.59e-05	0.000564	CcSEcCtD
Apixaban—Dizziness—Thiotepa—breast cancer	6.52e-05	0.000558	CcSEcCtD
Apixaban—Rash—Vinorelbine—breast cancer	6.51e-05	0.000557	CcSEcCtD
Apixaban—Dermatitis—Vinorelbine—breast cancer	6.5e-05	0.000557	CcSEcCtD
Apixaban—Hypotension—Paclitaxel—breast cancer	6.49e-05	0.000555	CcSEcCtD
Apixaban—Syncope—Docetaxel—breast cancer	6.47e-05	0.000554	CcSEcCtD
Apixaban—Anaemia—Capecitabine—breast cancer	6.45e-05	0.000552	CcSEcCtD
Apixaban—Haematuria—Methotrexate—breast cancer	6.34e-05	0.000543	CcSEcCtD
Apixaban—Loss of consciousness—Docetaxel—breast cancer	6.34e-05	0.000543	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—breast cancer	6.29e-05	0.000538	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—breast cancer	6.27e-05	0.000537	CcSEcCtD
Apixaban—Hypersensitivity—Irinotecan—breast cancer	6.27e-05	0.000537	CcSEcCtD
Apixaban—Hypersensitivity—Mitoxantrone—breast cancer	6.27e-05	0.000537	CcSEcCtD
Apixaban—Syncope—Capecitabine—breast cancer	6.26e-05	0.000536	CcSEcCtD
Apixaban—Rash—Thiotepa—breast cancer	6.22e-05	0.000532	CcSEcCtD
Apixaban—Dermatitis—Thiotepa—breast cancer	6.21e-05	0.000532	CcSEcCtD
Apixaban—Loss of consciousness—Capecitabine—breast cancer	6.14e-05	0.000525	CcSEcCtD
Apixaban—Nausea—Vinorelbine—breast cancer	6.13e-05	0.000525	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.1e-05	0.000522	CcSEcCtD
Apixaban—Hypersensitivity—Fluorouracil—breast cancer	6.01e-05	0.000514	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—breast cancer	6e-05	0.000514	CcSEcCtD
Apixaban—Gastrointestinal disorder—Paclitaxel—breast cancer	5.99e-05	0.000513	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—breast cancer	5.97e-05	0.000511	CcSEcCtD
Apixaban—Haematuria—Epirubicin—breast cancer	5.93e-05	0.000508	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.9e-05	0.000505	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—breast cancer	5.9e-05	0.000505	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—breast cancer	5.89e-05	0.000504	CcSEcCtD
Apixaban—Anaphylactic shock—Docetaxel—breast cancer	5.89e-05	0.000504	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—breast cancer	5.87e-05	0.000503	CcSEcCtD
Apixaban—Nausea—Thiotepa—breast cancer	5.86e-05	0.000501	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—breast cancer	5.85e-05	0.000501	CcSEcCtD
Apixaban—Shock—Docetaxel—breast cancer	5.79e-05	0.000496	CcSEcCtD
Apixaban—Nervous system disorder—Docetaxel—breast cancer	5.77e-05	0.000494	CcSEcCtD
Apixaban—Thrombocytopenia—Docetaxel—breast cancer	5.76e-05	0.000493	CcSEcCtD
Apixaban—Skin disorder—Docetaxel—breast cancer	5.72e-05	0.000489	CcSEcCtD
Apixaban—Dizziness—Irinotecan—breast cancer	5.63e-05	0.000482	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—breast cancer	5.62e-05	0.000481	CcSEcCtD
Apixaban—Shock—Capecitabine—breast cancer	5.61e-05	0.00048	CcSEcCtD
Apixaban—Nervous system disorder—Capecitabine—breast cancer	5.59e-05	0.000478	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—breast cancer	5.59e-05	0.000478	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—breast cancer	5.58e-05	0.000478	CcSEcCtD
Apixaban—Thrombocytopenia—Capecitabine—breast cancer	5.58e-05	0.000478	CcSEcCtD
Apixaban—Skin disorder—Capecitabine—breast cancer	5.53e-05	0.000474	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—breast cancer	5.52e-05	0.000472	CcSEcCtD
Apixaban—Hypotension—Docetaxel—breast cancer	5.5e-05	0.000471	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—breast cancer	5.49e-05	0.00047	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—breast cancer	5.49e-05	0.00047	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—breast cancer	5.48e-05	0.000469	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—breast cancer	5.45e-05	0.000466	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—breast cancer	5.43e-05	0.000465	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—breast cancer	5.42e-05	0.000464	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—breast cancer	5.39e-05	0.000462	CcSEcCtD
Apixaban—Dizziness—Fluorouracil—breast cancer	5.39e-05	0.000462	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—breast cancer	5.38e-05	0.000461	CcSEcCtD
Apixaban—Rash—Irinotecan—breast cancer	5.37e-05	0.00046	CcSEcCtD
Apixaban—Rash—Mitoxantrone—breast cancer	5.37e-05	0.00046	CcSEcCtD
Apixaban—Dermatitis—Mitoxantrone—breast cancer	5.36e-05	0.000459	CcSEcCtD
Apixaban—Dermatitis—Irinotecan—breast cancer	5.36e-05	0.000459	CcSEcCtD
Apixaban—Hypotension—Capecitabine—breast cancer	5.32e-05	0.000456	CcSEcCtD
Apixaban—Rash—Gemcitabine—breast cancer	5.23e-05	0.000448	CcSEcCtD
Apixaban—Dermatitis—Gemcitabine—breast cancer	5.22e-05	0.000447	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—breast cancer	5.22e-05	0.000447	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—breast cancer	5.2e-05	0.000445	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—breast cancer	5.17e-05	0.000443	CcSEcCtD
Apixaban—Rash—Fluorouracil—breast cancer	5.14e-05	0.00044	CcSEcCtD
Apixaban—Dermatitis—Fluorouracil—breast cancer	5.14e-05	0.00044	CcSEcCtD
Apixaban—Hypersensitivity—Paclitaxel—breast cancer	5.12e-05	0.000438	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—breast cancer	5.11e-05	0.000437	CcSEcCtD
Apixaban—Gastrointestinal disorder—Docetaxel—breast cancer	5.08e-05	0.000435	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—breast cancer	5.08e-05	0.000435	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—breast cancer	5.07e-05	0.000434	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—breast cancer	5.07e-05	0.000434	CcSEcCtD
Apixaban—Nausea—Irinotecan—breast cancer	5.06e-05	0.000433	CcSEcCtD
Apixaban—Nausea—Mitoxantrone—breast cancer	5.06e-05	0.000433	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—breast cancer	5.05e-05	0.000432	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—breast cancer	5.04e-05	0.000431	CcSEcCtD
Apixaban—Nausea—Gemcitabine—breast cancer	4.93e-05	0.000422	CcSEcCtD
Apixaban—Gastrointestinal disorder—Capecitabine—breast cancer	4.92e-05	0.000421	CcSEcCtD
Apixaban—Nausea—Fluorouracil—breast cancer	4.84e-05	0.000415	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—breast cancer	4.83e-05	0.000414	CcSEcCtD
Apixaban—Anaemia—Methotrexate—breast cancer	4.8e-05	0.000411	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—breast cancer	4.69e-05	0.000402	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—breast cancer	4.67e-05	0.0004	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—breast cancer	4.66e-05	0.000399	CcSEcCtD
Apixaban—Dizziness—Paclitaxel—breast cancer	4.59e-05	0.000393	CcSEcCtD
Apixaban—Anaemia—Epirubicin—breast cancer	4.5e-05	0.000385	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.39e-05	0.000376	CcSEcCtD
Apixaban—Rash—Paclitaxel—breast cancer	4.38e-05	0.000375	CcSEcCtD
Apixaban—Dermatitis—Paclitaxel—breast cancer	4.37e-05	0.000374	CcSEcCtD
Apixaban—Syncope—Epirubicin—breast cancer	4.36e-05	0.000373	CcSEcCtD
Apixaban—Hypersensitivity—Docetaxel—breast cancer	4.34e-05	0.000371	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—breast cancer	4.28e-05	0.000366	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—breast cancer	4.24e-05	0.000363	CcSEcCtD
Apixaban—Hypersensitivity—Capecitabine—breast cancer	4.2e-05	0.000359	CcSEcCtD
Apixaban—Nervous system disorder—Methotrexate—breast cancer	4.16e-05	0.000356	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—breast cancer	4.16e-05	0.000356	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—breast cancer	4.15e-05	0.000356	CcSEcCtD
Apixaban—Nausea—Paclitaxel—breast cancer	4.12e-05	0.000353	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—breast cancer	4.12e-05	0.000353	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.11e-05	0.000352	CcSEcCtD
Apixaban—Syncope—Doxorubicin—breast cancer	4.04e-05	0.000345	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—breast cancer	3.97e-05	0.00034	CcSEcCtD
Apixaban—Hypotension—Methotrexate—breast cancer	3.96e-05	0.000339	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—breast cancer	3.96e-05	0.000339	CcSEcCtD
Apixaban—Shock—Epirubicin—breast cancer	3.91e-05	0.000334	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—breast cancer	3.89e-05	0.000333	CcSEcCtD
Apixaban—Dizziness—Docetaxel—breast cancer	3.89e-05	0.000333	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—breast cancer	3.89e-05	0.000333	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—breast cancer	3.86e-05	0.00033	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.81e-05	0.000326	CcSEcCtD
Apixaban—Dizziness—Capecitabine—breast cancer	3.77e-05	0.000323	CcSEcCtD
Apixaban—Rash—Docetaxel—breast cancer	3.71e-05	0.000318	CcSEcCtD
Apixaban—Hypotension—Epirubicin—breast cancer	3.71e-05	0.000318	CcSEcCtD
Apixaban—Dermatitis—Docetaxel—breast cancer	3.71e-05	0.000317	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—breast cancer	3.67e-05	0.000314	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—breast cancer	3.66e-05	0.000313	CcSEcCtD
Apixaban—Shock—Doxorubicin—breast cancer	3.61e-05	0.000309	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—breast cancer	3.6e-05	0.000308	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—breast cancer	3.6e-05	0.000308	CcSEcCtD
Apixaban—Rash—Capecitabine—breast cancer	3.59e-05	0.000308	CcSEcCtD
Apixaban—Dermatitis—Capecitabine—breast cancer	3.59e-05	0.000307	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—breast cancer	3.57e-05	0.000305	CcSEcCtD
Apixaban—Nausea—Docetaxel—breast cancer	3.5e-05	0.000299	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—breast cancer	3.43e-05	0.000294	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—breast cancer	3.43e-05	0.000293	CcSEcCtD
Apixaban—Nausea—Capecitabine—breast cancer	3.38e-05	0.00029	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—breast cancer	3.17e-05	0.000271	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—breast cancer	3.13e-05	0.000268	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—breast cancer	2.92e-05	0.00025	CcSEcCtD
Apixaban—Dizziness—Methotrexate—breast cancer	2.81e-05	0.00024	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—breast cancer	2.71e-05	0.000232	CcSEcCtD
Apixaban—Rash—Methotrexate—breast cancer	2.67e-05	0.000229	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—breast cancer	2.67e-05	0.000229	CcSEcCtD
Apixaban—Dizziness—Epirubicin—breast cancer	2.63e-05	0.000225	CcSEcCtD
Apixaban—Nausea—Methotrexate—breast cancer	2.52e-05	0.000216	CcSEcCtD
Apixaban—Rash—Epirubicin—breast cancer	2.5e-05	0.000214	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—breast cancer	2.5e-05	0.000214	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—breast cancer	2.43e-05	0.000208	CcSEcCtD
Apixaban—Nausea—Epirubicin—breast cancer	2.36e-05	0.000202	CcSEcCtD
Apixaban—Rash—Doxorubicin—breast cancer	2.32e-05	0.000198	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—breast cancer	2.31e-05	0.000198	CcSEcCtD
Apixaban—Nausea—Doxorubicin—breast cancer	2.18e-05	0.000187	CcSEcCtD
Apixaban—CYP2J2—Metabolism—AKT1—breast cancer	3.13e-06	3.51e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.11e-06	3.49e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HPGDS—breast cancer	3.1e-06	3.48e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SULT1A1—breast cancer	3.1e-06	3.48e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX4—breast cancer	3.1e-06	3.48e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HBA1—breast cancer	3.08e-06	3.46e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FASN—breast cancer	3.08e-06	3.46e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1B1—breast cancer	3.08e-06	3.45e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—BCHE—breast cancer	3.07e-06	3.44e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP3A4—breast cancer	3.05e-06	3.43e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPX1—breast cancer	3.05e-06	3.42e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.04e-06	3.41e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC5A5—breast cancer	3.03e-06	3.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—IDH1—breast cancer	3.03e-06	3.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTA1—breast cancer	3.03e-06	3.4e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.02e-06	3.39e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1A1—breast cancer	3.02e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—COMT—breast cancer	3.01e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—breast cancer	3.01e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ACHE—breast cancer	3.01e-06	3.38e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1B1—breast cancer	3e-06	3.37e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—breast cancer	3e-06	3.37e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NAT2—breast cancer	3e-06	3.36e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ERCC2—breast cancer	2.99e-06	3.36e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.99e-06	3.35e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—breast cancer	2.96e-06	3.32e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ITPR1—breast cancer	2.95e-06	3.31e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HSP90AA1—breast cancer	2.95e-06	3.31e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NCOA1—breast cancer	2.94e-06	3.29e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC2A1—breast cancer	2.93e-06	3.28e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NQO1—breast cancer	2.93e-06	3.28e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CD—breast cancer	2.9e-06	3.25e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—STK11—breast cancer	2.89e-06	3.25e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP19A1—breast cancer	2.89e-06	3.25e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.87e-06	3.22e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NCOA1—breast cancer	2.87e-06	3.22e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—breast cancer	2.86e-06	3.21e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP3A4—breast cancer	2.85e-06	3.2e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP17A1—breast cancer	2.85e-06	3.2e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.84e-06	3.19e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—breast cancer	2.84e-06	3.19e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—STK11—breast cancer	2.82e-06	3.17e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP19A1—breast cancer	2.82e-06	3.17e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ENO1—breast cancer	2.82e-06	3.16e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS1—breast cancer	2.82e-06	3.16e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—breast cancer	2.81e-06	3.16e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.81e-06	3.15e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1B1—breast cancer	2.81e-06	3.15e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TYMS—breast cancer	2.79e-06	3.13e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.77e-06	3.11e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2D6—breast cancer	2.77e-06	3.1e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NCOR1—breast cancer	2.76e-06	3.09e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—breast cancer	2.76e-06	3.09e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.76e-06	3.09e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.75e-06	3.09e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—breast cancer	2.74e-06	3.07e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.72e-06	3.05e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NCOA2—breast cancer	2.71e-06	3.05e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—COMT—breast cancer	2.69e-06	3.02e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—breast cancer	2.68e-06	3e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NCOA1—breast cancer	2.68e-06	3e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—breast cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPX1—breast cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—STK11—breast cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP19A1—breast cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ITPR1—breast cancer	2.63e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FASN—breast cancer	2.63e-06	2.95e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MED12—breast cancer	2.63e-06	2.95e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—DPYD—breast cancer	2.63e-06	2.95e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—COMT—breast cancer	2.63e-06	2.95e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BCHE—breast cancer	2.62e-06	2.94e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—breast cancer	2.61e-06	2.93e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1A1—breast cancer	2.61e-06	2.93e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAV1—breast cancer	2.59e-06	2.91e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ERCC2—breast cancer	2.59e-06	2.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC5A5—breast cancer	2.59e-06	2.91e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDOA—breast cancer	2.59e-06	2.9e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—breast cancer	2.58e-06	2.89e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ITPR1—breast cancer	2.57e-06	2.89e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—breast cancer	2.53e-06	2.84e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CB—breast cancer	2.53e-06	2.84e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOA3—breast cancer	2.51e-06	2.82e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—breast cancer	2.5e-06	2.81e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A1—breast cancer	2.5e-06	2.81e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NQO1—breast cancer	2.5e-06	2.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A2—breast cancer	2.49e-06	2.8e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TYMS—breast cancer	2.49e-06	2.79e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.48e-06	2.78e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—breast cancer	2.46e-06	2.76e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NCOR1—breast cancer	2.46e-06	2.76e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.46e-06	2.76e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—COMT—breast cancer	2.45e-06	2.75e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.45e-06	2.75e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTR—breast cancer	2.44e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CPT1A—breast cancer	2.44e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCG2—breast cancer	2.44e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—breast cancer	2.44e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP3A4—breast cancer	2.44e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—breast cancer	2.44e-06	2.73e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TYMS—breast cancer	2.43e-06	2.73e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.43e-06	2.72e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—breast cancer	2.41e-06	2.7e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ITPR1—breast cancer	2.4e-06	2.7e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLA2G4A—breast cancer	2.4e-06	2.69e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NCOR1—breast cancer	2.4e-06	2.69e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—breast cancer	2.4e-06	2.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1B1—breast cancer	2.4e-06	2.69e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HPGDS—breast cancer	2.39e-06	2.69e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HBA1—breast cancer	2.38e-06	2.67e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—breast cancer	2.36e-06	2.65e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPX1—breast cancer	2.36e-06	2.64e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.35e-06	2.64e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1A1—breast cancer	2.33e-06	2.62e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—breast cancer	2.32e-06	2.61e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ACHE—breast cancer	2.32e-06	2.61e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ERCC2—breast cancer	2.31e-06	2.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—breast cancer	2.31e-06	2.59e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPX1—breast cancer	2.3e-06	2.58e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NCOA1—breast cancer	2.29e-06	2.57e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1A1—breast cancer	2.28e-06	2.55e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TYMS—breast cancer	2.27e-06	2.55e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ERCC2—breast cancer	2.26e-06	2.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—STK11—breast cancer	2.25e-06	2.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP19A1—breast cancer	2.25e-06	2.53e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAV1—breast cancer	2.25e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NCOR1—breast cancer	2.24e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—breast cancer	2.24e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.24e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP17A1—breast cancer	2.2e-06	2.47e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—breast cancer	2.18e-06	2.45e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS1—breast cancer	2.18e-06	2.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ENO1—breast cancer	2.18e-06	2.44e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—breast cancer	2.17e-06	2.44e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPX1—breast cancer	2.15e-06	2.41e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.15e-06	2.41e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2D6—breast cancer	2.13e-06	2.39e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1A1—breast cancer	2.13e-06	2.39e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—breast cancer	2.12e-06	2.38e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.12e-06	2.37e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ERCC2—breast cancer	2.11e-06	2.37e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—COMT—breast cancer	2.1e-06	2.35e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOA2—breast cancer	2.09e-06	2.35e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—breast cancer	2.09e-06	2.34e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CD—breast cancer	2.08e-06	2.33e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—breast cancer	2.06e-06	2.31e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ITPR1—breast cancer	2.05e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—breast cancer	2.05e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—breast cancer	2.05e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FASN—breast cancer	2.03e-06	2.28e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BCHE—breast cancer	2.02e-06	2.27e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAV1—breast cancer	2.01e-06	2.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC5A5—breast cancer	2e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—breast cancer	1.98e-06	2.22e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—breast cancer	1.97e-06	2.22e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—breast cancer	1.96e-06	2.2e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAV1—breast cancer	1.96e-06	2.2e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TYMS—breast cancer	1.94e-06	2.18e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NQO1—breast cancer	1.93e-06	2.17e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A1—breast cancer	1.93e-06	2.17e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.92e-06	2.15e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NCOR1—breast cancer	1.92e-06	2.15e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—breast cancer	1.92e-06	2.15e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.92e-06	2.15e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1B1—breast cancer	1.85e-06	2.08e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPX1—breast cancer	1.84e-06	2.06e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAV1—breast cancer	1.83e-06	2.05e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—breast cancer	1.83e-06	2.05e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1A1—breast cancer	1.82e-06	2.04e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.81e-06	2.04e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CB—breast cancer	1.81e-06	2.03e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ERCC2—breast cancer	1.8e-06	2.02e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CD—breast cancer	1.8e-06	2.02e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—breast cancer	1.79e-06	2.01e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—breast cancer	1.78e-06	2e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—breast cancer	1.78e-06	1.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOA1—breast cancer	1.77e-06	1.98e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.75e-06	1.96e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP19A1—breast cancer	1.74e-06	1.95e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—STK11—breast cancer	1.74e-06	1.95e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—breast cancer	1.7e-06	1.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—breast cancer	1.69e-06	1.9e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—breast cancer	1.67e-06	1.87e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—COMT—breast cancer	1.62e-06	1.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—breast cancer	1.61e-06	1.81e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CD—breast cancer	1.61e-06	1.8e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—breast cancer	1.59e-06	1.78e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—breast cancer	1.59e-06	1.78e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ITPR1—breast cancer	1.58e-06	1.78e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CB—breast cancer	1.57e-06	1.76e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CD—breast cancer	1.57e-06	1.76e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—breast cancer	1.56e-06	1.76e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAV1—breast cancer	1.56e-06	1.75e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—breast cancer	1.55e-06	1.74e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—breast cancer	1.55e-06	1.74e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—breast cancer	1.54e-06	1.73e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—breast cancer	1.52e-06	1.71e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—breast cancer	1.52e-06	1.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TYMS—breast cancer	1.5e-06	1.68e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.49e-06	1.68e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—breast cancer	1.48e-06	1.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOR1—breast cancer	1.48e-06	1.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.48e-06	1.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—breast cancer	1.48e-06	1.66e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CD—breast cancer	1.46e-06	1.64e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—breast cancer	1.45e-06	1.62e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—breast cancer	1.42e-06	1.6e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX1—breast cancer	1.42e-06	1.59e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1A1—breast cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CB—breast cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ERCC2—breast cancer	1.39e-06	1.56e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—breast cancer	1.39e-06	1.56e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—breast cancer	1.38e-06	1.55e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CB—breast cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—breast cancer	1.36e-06	1.52e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—breast cancer	1.35e-06	1.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—breast cancer	1.31e-06	1.47e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CB—breast cancer	1.28e-06	1.43e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—breast cancer	1.26e-06	1.42e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—breast cancer	1.26e-06	1.41e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CD—breast cancer	1.25e-06	1.4e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—breast cancer	1.24e-06	1.39e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—breast cancer	1.21e-06	1.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAV1—breast cancer	1.21e-06	1.35e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—breast cancer	1.18e-06	1.33e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—breast cancer	1.18e-06	1.32e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—breast cancer	1.1e-06	1.24e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—breast cancer	1.1e-06	1.24e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—breast cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CB—breast cancer	1.09e-06	1.22e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—breast cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CD—breast cancer	9.66e-07	1.08e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—breast cancer	9.56e-07	1.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—breast cancer	9.53e-07	1.07e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—breast cancer	9.42e-07	1.06e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—breast cancer	9.12e-07	1.02e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—breast cancer	9.02e-07	1.01e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—breast cancer	8.53e-07	9.57e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CB—breast cancer	8.42e-07	9.45e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—breast cancer	8.34e-07	9.36e-06	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—breast cancer	8.33e-07	9.35e-06	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—breast cancer	7.81e-07	8.76e-06	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—breast cancer	7.78e-07	8.73e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—breast cancer	7.27e-07	8.16e-06	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—breast cancer	6.97e-07	7.82e-06	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—breast cancer	6.8e-07	7.63e-06	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—breast cancer	6.65e-07	7.46e-06	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—breast cancer	6.36e-07	7.13e-06	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—breast cancer	5.43e-07	6.09e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—breast cancer	5.13e-07	5.76e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—breast cancer	4.19e-07	4.7e-06	CbGpPWpGaD
